Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
SchaeffersResearch.com6h
Moderna Stock Falls on Vaccine Revenue Concerns
Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs. The firm ...
Officials: Bird flu spreading in state, but cases still low in Central Mass.
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Moderna stock drops as Goldman Sachs cuts rating
Moderna (NASDAQ: MRNA) shares fell over 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy. The downgrade follows a series of negative revisions to ...
Oxford Mail on MSN4h
Moderna says government has shown 'commitment to growth and innovation'
Vaccine manufacturer Moderna has welcomed the Chancellor's announcements regarding major infrastructure schemes.
Caroline Kennedy calls cousin RFK Jr. a ‘predator’ ahead of his confirmation hearings to be Trump’s health secretary
Caroline Kennedy on Tuesday warned that her cousin Robert F. Kennedy Jr. is a “predator” ahead of his high-profile ...
From Underperformance To Opportunity: Biotech's Case For 2025
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Dr. Sanjay Gupta: Benefits of vaccines are a matter of fact
I have started, scratched out and even abandoned the writing of this essay. I couldn’t do it. It wasn’t there. Didn’t feel it ...